FDC Limited (BOM:531599)
354.40
+0.10 (0.03%)
At close: Aug 17, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 57.7 billion as of August 17, 2026. Its market cap has decreased by -25.63% in one year.
Market Cap
57.70B
Enterprise Value
52.63B
Revenue
21.90B
Ranking
n/a
PE Ratio
19.71
Stock Price
354.40
ChartMarket Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 57.70B, an increase of 2,015.46%. That is a compound annual growth rate of 13.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 57.70B | -16.28% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 111.56B |
| Procter & Gamble Health | 98.50B |
| Sanofi India | 74.77B |
| Bliss GVS Pharma | 55.68B |
| Morepen Laboratories | 46.15B |
| Gufic Biosciences | 42.24B |
| Novartis India | 39.18B |
| Unichem Laboratories | 37.93B |